HC Wainwright & Co. Maintains Buy on Instil Bio, Raises Price Target to $120
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor maintains a Buy rating on Instil Bio (NASDAQ:TIL) and raises the price target from $40 to $120.
September 16, 2024 | 5:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has increased the price target for Instil Bio from $40 to $120, maintaining a Buy rating. This suggests strong confidence in the company's future performance.
The significant increase in the price target from $40 to $120 by a reputable analyst indicates strong expected growth and potential upside for Instil Bio. This is likely to positively influence investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100